Last update: 03.07.2024 10:12 (GMT+3)

GRD: About the invitation to submit application for the acquisition of pharmaceutical company “Jelfa

12.10.2005, Grindeks, RIG
Grindeks                                                        12.10.2005

JSC Grindeks informs about the invitation to repeatedly submit its application
for the acquisition of the shares of pharmaceutical company “Jelfa S.A”

On October 5, JSC Grindeks received an official letter from the Industrial
Development Agency (IDA) of Poland with the invitation to repeatedly submit
its application for the acquisition of the share stock making 47, 83% of
total Jelfa’s share capital.


After the evaluation of the previously submitted applications concerning
price proposal and other conditions Industrial Development Agency (IDA) of
Poland has accepted JSC Grindeks as one of the applicants for the acquisition
of the share capital owned by the State institutions. Participation in the
auction for the above mentioned 47,83% share capital is set to be in several
stages. First stage of this auction was beneficial for the JSC Grindeks.

As it is mentioned before JSC Grindeks on June 6 as a response to the letter
from IDA inviting Grindeks to take part in the process of privatization of
Jelfa’s share capital belonging to the State institutions submitted its
application at the Industrial Development Agency (IDA) of Poland expressing
an interest to purchase the share capital of the pharmaceutical company
Jelfa S.A.

For this moment state institution owned shares 47.83 % is divided into - 26.1%
of „Jelfa” share capital belongs to the Industrial Development Agency (IDA) of
Poland, 3.9% to the Ministry of State Treasury, 16.7% to the State Insurance
Joint Stock Company.


Information prepared by:
Finance and Administrative director
JSC Grindeks
Office: 7083250,
GSM: 9226767
e-mail: janis_romanovskis@grindeks.lv

Tradable Assets

Shares
Bonds
Funds

Market information

Statistics
Trading
Indexes
Auctions

Market Regulation

Rules and Regulations
Surveillance

Get Started

For Companies
For Investors
For Brokers/Members
For First North Advisers

News

Nasdaq News
Issuer News
Calendar

About Us

Nasdaq Baltic Market
Offices